about
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsHigh density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskHDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsWill Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections.Aging affects high-density lipoprotein composition and function.Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus.Restoration of renal function does not correct impairment of uremic HDL propertiesLipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesOptical Properties of Europium Tetracycline Complexes in the Presence of High-Density Lipoproteins (HDL) Subfractions.Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein functionGlycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.Can Xanthophyll-Membrane Interactions Explain Their Selective Presence in the Retina and Brain?The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight lossHigh density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseSynthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state.Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults.High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.Revising the high-density lipoprotein targeting strategies - insights from human and preclinical studies.Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.HDL particle subpopulations: Focus on biological function.High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.Advances in high-density lipoprotein physiology: surprises, overturns, and promises.Kidney function is associated with an altered protein composition of high-density lipoprotein.Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice.A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activationHigh-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia.Response to letter regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy".
P2860
Q26750603-7195FAEB-0379-4B30-96A2-0C28A24FF2C8Q26774903-3446BE2A-8A8F-43B8-A32A-62D24BB97BC9Q26775420-1FB50B22-76DA-44FA-BA58-7B2E5A3410B1Q26779667-B4E6D102-E719-4A11-B548-2771FFF965A9Q28080768-EC683B79-DB62-438D-912D-B05042F29B45Q30251918-C3F2B888-D716-4611-9D7C-B3BB8988EF4AQ33837659-5FE9DEFE-10C0-4C40-9F21-E7E0A25D5838Q34781392-97D1FD66-B91B-4B55-8F29-E4F8200423D7Q35114943-D343F2A7-1DAA-4DCA-99A0-D351CFF300EAQ35124223-40CF9FDB-15A6-4730-9C2D-30EE34ED082EQ35209036-DD194547-EC74-43F2-BCAC-36F11789ED9AQ35994365-600C52E7-E0FC-4A40-AEB2-B4C275AE6DA1Q36221157-A95F9A13-44FD-422A-A6CF-255A014BBF1FQ36560360-32FE182A-A83B-4DFF-9A16-9F0FB04374D0Q36681220-1297C4DC-C30D-499E-B8CF-594C3741D67FQ36718110-2F9B6CD4-5291-4425-9845-461F0406DB0EQ36733416-863FD620-9418-4BFB-AA76-47505BB0B82DQ36807054-DB39BA5C-1AE6-4DAF-BC57-C2897183EC04Q37305341-00C5A27A-EFC0-42C0-BE00-3173155F91B2Q37446423-07FBADE8-C2FA-4454-8E92-6932A9F277B4Q37643353-F7250C0A-19AA-4B8B-84CA-5AFE43783FDDQ37661249-70790A90-9471-4B13-B182-702AE6D74FF8Q37716377-5C025624-FEA3-4B49-90EA-5BB54E476753Q37726891-E0EE3223-1F3F-4962-A23F-436BFBACE872Q38220761-C6488DE9-233D-4C30-AB7D-27E5B93A7EEAQ38239205-B10A148C-0C52-438E-8031-973F444805D8Q38363617-AF44E9A9-C455-46E5-84EE-E5B37B052746Q38391229-14A14BDE-157B-41FA-9F09-4A56BF4E9EC8Q38436472-E4ECAB6A-89D5-45CF-92CE-1228F17430E3Q38623588-BF2F766C-DE29-476C-B48F-CE544A9831CFQ38650168-7773BB74-610E-40B2-AE76-544EC9433E68Q38682093-C74B4A27-22E1-400B-8DCF-D9913FAA28ADQ38803730-4DAE9CC1-5CF2-4348-8951-197394FABFCAQ38822339-16912EA9-4F31-4BFF-9978-66DFD9A724ADQ39450537-630A5927-6A1E-4B1A-A448-5EAE0DD3B8FDQ40966020-3189864E-C129-4CCE-AAFC-7011F3CD71DEQ41387814-D5846F1E-439C-4303-9EC2-2246C609A92FQ41497977-5ADCB08F-2A10-4766-9823-A5490FE8D0A6Q42725914-C1F690B7-C767-4226-A68D-9CFC96402930Q43239030-C79A3887-A02F-44FE-9FB3-C4D84C8407BE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unraveling the complexities of the HDL lipidome
@en
Unraveling the complexities of the HDL lipidome.
@nl
type
label
Unraveling the complexities of the HDL lipidome
@en
Unraveling the complexities of the HDL lipidome.
@nl
prefLabel
Unraveling the complexities of the HDL lipidome
@en
Unraveling the complexities of the HDL lipidome.
@nl
P2093
P2860
P356
P1476
Unraveling the complexities of the HDL lipidome
@en
P2093
Anatol Kontush
M John Chapman
Marie Lhomme
P2860
P304
P356
10.1194/JLR.R036095
P577
2013-03-30T00:00:00Z